aaaand some wonderful post-hoc analysis and missing data. Where are the 6 month results in the charts? Can anyone find any prior mention of "ACR-N" or "ACR-N AUC"? Where are the patient baselines? How come at 39 weeks the dose related response disappears with 1M/kg outperforming 2M/kg?
The data are also clearly wrong - How can it be that with N=11 you get 60%/30%/30% in the subgroup analysis? if 6 responded that's 55, if 7 responded that's 64%. Same with the N=10.
aaaand some wonderful post-hoc analysis and missing data. Where...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45345 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3875 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |